Results 311 to 320 of about 11,050,255 (347)

Development of Innovative Biomaterials and Devices for the Treatment of Cardiovascular Diseases

Advances in Materials, 2022
Cardiovascular diseases have become the leading cause of death worldwide. The increasing burden of cardiovascular diseases has become a major public health problem and how to carry out efficient and reliable treatment of cardiovascular diseases has ...
Yunbing Wang   +4 more
semanticscholar   +1 more source

China cardiovascular diseases report 2018: an updated summary

Journal of Geriatric Cardiology, 2020
Rapid socioeconomic progress has greatly affected the lifestyle in China. Consequently, owing to lifestyle changes, urbanization, and accelerated population aging, the risk of cardiovascular diseases (CVD) has increased.
Li-Yuan Ma   +11 more
semanticscholar   +1 more source

Periodontal Disease and Cardiovascular Disease

Journal of Periodontology, 1996
It is our central hypothesis that periodontal diseases, which are chronic Gramnegative infections, represent a previously unrecognized risk factor for atherosclerosis and thromboembolic events. Previous studies have demonstrated an association between periodontal disease severity and risk of coronary heart disease and stroke.
James, Beck   +4 more
openaire   +3 more sources

Cardiovascular disease

Primary Care: Clinics in Office Practice, 2002
The primary care physician is in a position to advise patients on the efficacy of alternative and complementary therapies as they relate to cardiovascular diseases. Anti-oxidant vitamin supplementation has not been shown to be efficacious in decreasing cardiovascular events.
openaire   +2 more sources

Platelets and cardiovascular disease

European Journal of Cardiovascular Nursing, 2002
Platelets play an important, but often under-recognized role in cardiovascular disease. For example, the normal response of the platelet can be altered, either by increased pro-aggregatory stimuli or by diminished anti-aggregatory substances to produce conditions of increased platelet activation/aggregation and occur in active cardiovascular disease ...
Scott, Willoughby   +2 more
openaire   +2 more sources

Leukotrienes in Cardiovascular Diseases

American Journal of Respiratory and Critical Care Medicine, 2000
Cysteinyl-leukotrienes (cys-LTs, LTC4, LTD4,and LTE4) are potent lipid mediators, resulting from the oxidative metabolism of arachidonic acid through the 5-lipoxygenase (5-LO) pathway. They are able to affect all major components of the cardiovascular system: they can constrict small and large vessels, modify cardiac and coronary functions, influence ...
G. Folco   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy